Skip to main content

Frazier Life Sciences Acquisition Corp. II

FLSC
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002153598

In the last 90 days, Frazier Life Sciences Acquisition Corp. II insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Frazier Life Sciences Acquisition Corp. II insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $3.00M in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$3.00M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Frazier Life Sciences Acquisition Corp. II, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Frazier Life Sciences Acquisition Corp. II
NameTitleLast reported holdingLast filingFilings, past year
Cha AlbertChief Executive Officer300,000IndirectOct 15, 20261
Frazier Life Sciences Public Fund, L.P.10% Owner300,000IndirectOct 15, 20261
FHMLSP, L.L.C.10% Owner300,000IndirectOct 15, 20261
FHMLSP, L.P.10% Owner300,000IndirectOct 15, 20261
Frazier Life Sciences Holdings II LLC10% Owner300,000IndirectOct 15, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 15, 2026 (view filing)4:40 PM ETOct 15Same dayCha Albert and 4 othersChief Executive OfficerPPurchaseClass A ordinary shares+300.0K$10.00+$3.00MNew position300.0K after